Childhood Cancer Survivor Study (CCSS)(Limited Competition U24)

The summary for the Childhood Cancer Survivor Study (CCSS)(Limited Competition U24) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Childhood Cancer Survivor Study (CCSS)(Limited Competition U24): The purpose of this Funding Opportunity Announcement (FOA) is to continue support for Childhood Cancer Survivor Study (CCSS) as a resource enabling broad studies on the long-term effects of cancer and its associated therapies on survivors of pediatric cancers. CCSS (originally funded as an investigator initiated program) serves the overall goal to quantify and better understand the effects of pediatric cancer and its treatment on later health of cancer survivors, including behavioral and sociodemographic outcomes. For these goals, CCSS has been designed as a comprehensive multicenter effort to comprehensively manage large cohorts of survivors of childhood cancer. The original cohort of study participants included 14,370 pediatric cancer survivors diagnosed between 1970 and 1986 as well as 3,737 siblings. Enrollment of a second cohort of survivors consisting of a similar number of subjects diagnosed between 1987 and 1999 is expected to be completed by the end of the current award period. The current CCSS structure includes 27 institutions, mostly in the U.S. but also in Canada.
Federal Grant Title: Childhood Cancer Survivor Study (CCSS)(Limited Competition U24)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-11-501
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.395
CFDA Descriptions: Cancer Treatment Research
Current Application Deadline: Apr 21, 2011
Original Application Deadline: Apr 21, 2011
Posted Date: February 17th, 2011
Creation Date: Feb 17, 2011
Archive Date: May 22, 2011
Total Program Funding: $4,380,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 1
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical...
Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial ...
Assay development and screening for discovery of chemical probes, drugs or immunomodulator...
Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clini...
Breast and Prostate Cancer Data Quality and Patterns of Care Study
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies in Adults
National Cooperative Drug Discovery Groups for Cancer
More Grants from the National Institutes of Health
HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com